18179-39-0

Basic information

• Product Name: METHYL 4-IODOSALICYLATE
• Synonyms: Methyl 2-Hydroxy-4-iodobenzoate 4-Iodosalicylic Acid Methyl Ester 2-Hydroxy-4-iodobenzoic Acid Methyl Ester;Methyl 4-iodosalicylate, 5-Iodo-2-(methoxycarbonyl)phenol;Methyl 4-iodosalicylate 97%;Methyl4-Iodosilicylate;2-Hydroxy-4-iodobenzoic Acid Methyl Ester;4-Iodosalicylic Acid Methyl Ester
• CAS NO: 18179-39-0
• Molecular Formula: C₈H₇IO₃
• Molecular Weight: 278.11925
• Mol File: 18179-39-0.mol

Chemical Properties

• Melting Point: 69-73 °C
• Boiling Point: 309.7 °C at 760 mmHg
• Flash Point: 141.1 °C
• Appearance: /
• Density: 1.88 g/cm³
• Vapor Pressure: 0.000344mmHg at 25°C
• Refractive Index: 1.633
• Storage Temp.: Keep in dark place,Inert atmosphere,Room temperature
• PKA: 8.91±0.10(Predicted)
• Sensitive: Light Sensitive
• CAS DataBase Reference: METHYL 4-IODOSALICYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 4-IODOSALICYLATE(18179-39-0)
• EPA Substance Registry System: METHYL 4-IODOSALICYLATE(18179-39-0)

Safety Data

• Hazard Codes: T
• Statements: 25
• Safety Statements: 45
• RIDADR: UN 2811 6.1/PG 3
• WGK Germany: 3
• F: 8
• PackingGroup: III
• Hazardous Substances Data: 18179-39-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 4-Iodosalicylate is used as a reagent for the synthesis of various pharmaceutical compounds. Its iodine substitution at the 4-position allows for the creation of complex molecules that can be utilized in the development of new drugs and medications.
Used in Organic Synthesis:
In the field of organic chemistry, Methyl 4-Iodosalicylate serves as a key intermediate in the synthesis of other complex organic compounds. Its unique structure and reactivity make it a valuable component in the preparation of a wide range of chemical products.

InChI:InChI=1/C8H7IO3/c1-12-8(11)6-3-2-5(9)4-7(6)10/h2-4,10H,1H3

Upstream product

• 67-56-1 methanol 
• 16870-28-3 4-iodosalicylic acid 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 124-41-4 sodium methylate 
• 65-49-6 4-Aminosalicylic acid 
• 4136-97-4 methyl 4-aminosalicylate 
• 74-88-4 methyl iodide 

Downstream Products

• 65427-16-9 N,2-dihydroxy-4-iodobenzamide 
• 89942-34-7 2-methoxy-4-iodobenzoic acid 
• 801240-07-3 2-(5-tert-butoxycarbonylamino-pentyloxy)-4-iodo-benzoic acid methyl ester 
• 801239-89-4 2-{2-[2-(3-tert-butoxycarbonylamino-propoxy)-ethoxy]-ethoxy}-4-iodo-benzoic acid methyl ester 
• 801240-08-4 2-(5-tert-butoxycarbonylamino-pentyloxy)-4-ethynyl-benzoic acid methyl ester 
• 801239-90-7 2-{2-[2-(3-tert-butoxycarbonylamino-propoxy)-ethoxy]-ethoxy}-4-ethynyl-benzoic acid methyl ester 
• 801240-09-5 2-(5-tert-butoxycarbonylamino-pentyloxy)-4-(6-methylamino-pyridin-2-ylethynyl)-benzoic acid methyl ester 
• 801240-10-8 2-(5-tert-butoxycarbonylamino-pentyloxy)-4-[2-(6-methylamino-pyridin-2-yl)-ethyl]-benzoic acid methyl ester 
• 801240-06-2 2-(5-tert-butoxycarbonylamino-pentyloxy)-4-[2-(6-methylamino-pyridin-2-yl)-ethyl]-benzoic acid 
• 801239-92-9 2-{2-[2-(3-tert-butoxycarbonylamino-propoxy)-ethoxy]-ethoxy}-4-[2-(6-methylamino-pyridin-2-yl)-ethyl]-benzoic acid methyl ester 
• 801239-91-8 2-{2-[2-(3-tert-butoxycarbonylamino-propoxy)-ethoxy]-ethoxy}-4-(6-methylamino-pyridin-2-ylethynyl)-benzoic acid methyl ester 
• 801239-93-0 2-{2-[2-(3-tert-butoxycarbonylamino-propoxy)-ethoxy]-ethoxy}-4-[2-(6-methylamino-pyridin-2-yl)-ethyl]-benzoic acid 
• 801239-48-5 3-{2-(5-tert-butoxycarbonylamino-pentyloxy)-4-[2-(6-methylamino-pyridin-2-yl)-ethyl]-benzoylamino}-2-(2,4,6-trimethyl-benzenesulfonylamino)-propionic acid tert-butyl ester 
• 801239-46-3 3-{2-{2-[2-(3-tert-butoxycarbonylamino-propoxy)-ethoxy]-ethoxy}-4-[2-(6-methylamino-pyridin-2-yl)-ethyl]-benzoylamino}-2-(2,4,6-trimethyl-benzenesulfonylamino)-propionic acid tert-butyl ester 

Relevant articles and documents

Three-Dimensional Porous Architectures Based on MnII/III Three-Blade Paddle Wheel Metallacryptates

Three metallacryptate supramolecular assemblies have been obtained using salicylhydroxamic acid derivatives (H3L). The three ligands differ in the residue at the para position with respect to the hydroxamic function (-H, -NH2, and -(

LANTHANIDE CLUSTERS AND METHODS OF USE THEREOF

The present invention is directed to multinuclear lanthanides chiral clusters, based on phenyl-oxazoline-amide (POxA) ligands, and to methods of use thereof. The chiral clusters of this invention are highly fluorescent with high stability.

Acetylene Bridged Linkers and Metal-Organic Frameworks (MOFs) Produced Thereof

Described are acetylene bridged linkers, metal-organic frameworks produced thereof, processes for producing the linkers and the metal-organic frameworks, and the use of the metal-organic frameworks. The metal-organic frameworks possess an enhanced ability to adsorb and desorb high amounts of gases, in particular methane or hydrogen. The metal-organic frameworks have a high porosity and, thus, a high inner surface.

ACETYLENE BRIDGED LINKERS AND METAL-ORGANIC FRAMEWORKS (MOFS) PRODUCED THEREOF

The present invention relates to acetylene bridged linkers, metal-organic frameworks produced thereof, processes for producing the linkers and the MOFs and their use.

Leaving group assistance in the La3+-catalyzed cleavage of dimethyl (o-methoxycarbonyl)aryl phosphate triesters in methanol

The catalytic methanolysis of a series of dimethyl aryl phosphate triesters where the aryl groups contain an o-methoxycarbonyl (o-CO2Me) substituent (4a-i) was studied at 25°C in methanol containing La 3+ at various concentrations and sspH. Determination of the second-order rate constant for La3+ 2-catalyzed cleavage of substrate 4a (dimethyl (o-methoxycarbonyl) phenyl phosphate) as a function of sspH was assessed in terms of a speciation diagram that showed that the process was catalyzed by La3+ 2(-OCH3)x dimers, where x = 1-5, that exhibit only a 5-fold difference in activity between all the species. The second-order catalytic rate constants (k2La) for the catalyzed methanolysis of 4a-i at sspH 8.7 fit a Bronsted relationship of log k2La= (-0.82 ± 0.11)sspKalg + (11.61 ± 1.48), where the gradient is shallower than that determined for a series of dimethyl aryl phosphates that do not contain the o-CO2Me substituent, log k2La = (-1.25 ± 0.06)s spKalg + (16.23 ± 0.75). Two main observations are that (1) the o-CO2Me group preferentially accelerates the cleavage of the phosphate triesters with poor leaving groups relative to those with good leaving groups and (2) it provides an increase in cleavage rate relative to those of comparable substrates that do not have that functional group, e.g., k2La(dimethyl o-(methoxycarbonyl) phenyl phosphate)/k2La(dimethyl phenyl phosphate) = 60. Activation parameters for the La3+2-catalyzed methanolysis of 4a and dimethyl 4-nitrophenyl phosphate show respective ΔH? (ΔS?) values of 3.3 kcal/mol (-47 cal/mol·K) and 0.7 kcal/mol (-46.5 cal/mol·K). The data are analyzed in terms of a concerted reaction where the catalytic complex (La3+2( -OCH3)x-1) binds to the three components of a rather loose transition state composed of a nucleophile CH3O -, a nucleofuge -OAr, and a central (RO)2P 2+-O- in a way that provides leaving group assistance to the departing aryloxy group.

Dissociative solvolytic cleavage of methyl (ortho-Carboxymethyl)Aryl phosphate diesters mediated by Yb3+ in methanol gives a 10 12-fold rate acceleration attributable to leaving group assistance

The Yb3+-catalyzed cleavage of a series of eight methyl aryl phosphates (2a-h) where the aryl groups all contain an ortho-methoxycarbonyl group was studied in acidic methanol from 1.34 ≤ spHs ≤ 3.34 at 25 °C. All substrates show saturation binding of the metal ion that is analyzed to provide a conditional binding constant (K)b for a 1:1 substrate/Yb3+ complex and catalytic rate constant (A cat) that varies between about 2 × 10-3 and 50 × 10-3 s-1 overthe range of substrates. Detailed analysis indicates that at very low c oncentration of Yb3+, 3 equiv of substrate are bound, and with increasing [Yb3+], the binding changes to a 1:1 complex which decomposes by a pathway independent of spHs over the range investigated. Control studies show that substrates without the o-methoxycarbonyl group still bind to the Yb 3+ with approximately the same strength as do the o-methoxycarbonyl containing substrates but have no observable reaction when bound. A Jaffe plot of the kcat vs substituent ?-values indicates that, during the catalyzed reactions of 2a-h, the phenoxy-O and C(O)OCH3 groups accommodate negative and positive charge respectively, the p phosphate and p c(o)OMe values being (1.84 ±0.11) and ( 0.85 ±0.14). For all these substrates, the final reaction products are dimethyl phosphate and the Yb3+ complex of the phenoxide. A study of the binding of the parent phenols to Yb3+ indicates that log(Kbind) = (0.84 ± 0.06)sspKa+ (3.4 ± 0.9), r2 = 0.9664 for phenols containing the o-methoxycarbonyl group; for those lacking that substituent log(Kb ind) = (0.96 ± 0.04)s spKa- (1.73 ± 0.4), (r2 = 0.99). For the catalyzed reacti on the βlg = -0.48, while the βeq = -0.95, leading to a Leffler parameter of α = 0.51. A mechanism is presented for the catalyzed reaction which is highly dissociative, having a transition state where the Yb3+ translocates during the cleavage reaction to assist the leaving group's departure with weak nucleophilic assistance by the solvent methanol. A comparison of the catalyzed rate of reaction with a computed rate of reaction attributable to solvent alone indicates that Yb3+ provides leaving group assistance on the order of 1012-fold, stabilizing the transition state for cleavage by some 16 kcal/mol.

Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists

A series of acrylic acids and their structurally related compounds were evaluated for their binding affinity to four EP receptor subtypes (EP1-4). Starting from the initial hit 3, which was discovered in our in-house library, compounds 4 and 5 were identified as new chemical leads as candidates for further optimization towards a selective EP3 receptor antagonist. The identification process of these compounds and their pharmacokinetic profiles are presented.

Compounds and Compositions as Tpo Mimetics

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated TPO activity, particularly disea

SULFONAMIDE DERIVATIVE HAVING PGD2 RECEPTOR ANTAGONISTIC ACTIVITY

A sulfonamide derivative having DP receptor antagonistic activity; and a medicinal composition and a therapeutic agent for allergic diseases which each contains the compound as an active ingredient. The derivative is a compound represented by the general formula (II): (II) (wherein ring A is an aromatic carbocycle, etc.; ring B is a nitrogenous nonaromatic heterocycle, etc.; ring C is an aromatic carbocycle, etc.; R1 is carboxy, etc.; R2's each independently is halogeno, etc.; R3 is optionally substituted alkyloxy, etc.; R4's each independently is halogeno, etc.; R5's each independently is optionally substituted alkyl, etc.; M is sulfonyl, etc.; Y is a single bond, etc.; L1 is a single bond, etc.; L2 is a single bond, etc.; k is 0, 1, 2, 3, or 4; n is 0, 1, or 2; and q is 0, 1, 2, or 3, provided that, for example, a) when ring B is a 6-membered nitrogenous heterocycle containing one or two nitrogen atoms and ring C is a benzene ring, then k is not 0), a pharmaceutically acceptable salt of the compound, or a hydrate of either.